Volume 13, Number 6—June 2007
Research
Isolation and Characterization of Novel Human Parechovirus from Clinical Samples
Kanako Watanabe*†, Masayasu Oie*, Masaya Higuchi*, Makoto Nishikawa†, and Masahiro Fujii*
Table 1
Neutralization activities of anti-HPeV antibodies using Vero cells*
| Antiserum | Virus |
|||
|---|---|---|---|---|
| NII561-2000 | HPeV-1 | HPeV-2 | HPeV-3 | |
| NII561-2000 | 160 | 10 | <10 | <10 |
| HPeV-1† | <10 | >1,280 | <10 | <10 |
| HPeV-2 | <10 | <10 | 160 | <10 |
| HPeV-3 | <10 | <10 | <10 | >1,280 |
*HPeV, human parechovirus.
†The HPeV strains used were Harris strain for HPeV-1, Williamson strain for HPeV-2, and A308/99 for HPeV-3.
